About Lecanemab
            
            Class: | Monoclonal antibody (IgG1) targeting amyloid-beta  
Use: | Treatment of Alzheimer’s disease in patients with confirmed presence of amyloid pathology  
Adult dose: | Initial dose of 5 mg/kg administered intravenously every two weeks, with a subsequent dose of 10 mg/kg after 2 weeks if tolerated  
Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended for use in children  
Side effects: | Infusion-related reactions, headache, amyloid-related imaging a
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (IgG1) targeting amyloid-beta
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of Alzheimer’s disease in patients with confirmed presence of amyloid pathology
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light; discard unused portion after 24 hours if stored at room temperature
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Eisai Inc., U.S.A
                    
                    
                    Package Size
                    200 mg/2 ml  1 Single Dose Glass Vial [2 ml]
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 1262.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 5 mg/kg administered intravenously every two weeks, with a subsequent dose of 10 mg/kg after 2 weeks if tolerated
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; not recommended for use in children
                    
                 
                
                
                    
                        Side Effects
                    
                    Infusion-related reactions, headache, amyloid-related imaging abnormalities (ARIA), nausea, and diarrhea
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Known hypersensitivity to lecanemab or any component of the formulation; caution in patients with a history of ARIA
         
        
        
            
                Important Warnings
            
            Risk of ARIA, particularly ARIA-E (edema) and ARIA-H (hemorrhage); monitor patients for signs and symptoms of ARIA; consider MRI screening before and during treatment
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.